Merck invests ⬠250M in new biotech development centre in Switzerland
Merck invests ⬠250M in new biotech development centre in Switzerland 07 July 2021 | News
image credit- businesswire
German firm Merck has announced the topping-out ceremony for its new Biotech Development Center in Corsier-sur-Vevey, Switzerland.
This investment of € 250 million, which was announced in January 2020, is intended to help secure the capacities for a cost-efficient and agile provision of clinical study medication in the long term, to shorten the development time of novel biological active ingredients and to meet the challenge of the increasingly complex production of biotechnological substances to master the next generation.